Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06233578 · ClinicalTrials.gov registry record · NA
ATTENUATE (rAdpad proTecTion drapE iN redUcing rAdiaTion Exposure) Trial
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
NCT06233578 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 1,000 participants.
The verdict
NCT06233578, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the impact of the RADPAD in proximal operators in a contemporary cardiac catheterization laboratory (CCL), during diagnostic, coronary and structural cardiac catheterization procedures, in a large prospective, randomized controlled trial. Up to 1,000 patient-cases and up to 100 proximal operator-subjects expected to be enrolled across 1 site. The proximal operator cohort is expected to include a few interventional cardiologist attending physicians, interventional cardiology fellows, cardiovascular disease fellows and physician assistants performing multiple cases each, which in total would amount to 1,000 cases performed by 100 proximal operators. The primary outcome of interest was relative exposure of the proximal operator between the guideline directed radiation protocols and RADPAD use vs. guideline directed radiation protocols alone.
Interventions
- DEVICE RADPAD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-01-10 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06233578
The ClinicalTrials.gov registry entry for NCT06233578 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RADPAD is the first listed.
NCT06233578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06233578 about?
NCT06233578 is a clinical study titled "ATTENUATE (rAdpad proTecTion drapE iN redUcing rAdiaTion Exposure) Trial". The purpose of this study is to examine the impact of the RADPAD in proximal operators in a contemporary cardiac catheterization laboratory (CCL), during diagnostic, coronary and structural cardiac catheterization procedures, in a large prospective, randomized controlled trial. Up to 1,000 patient-c...
What is the current status of trial NCT06233578?
This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2024-01-10. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT06233578?
The interventions under investigation include: RADPAD (DEVICE).
Who is sponsoring clinical trial NCT06233578?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.